Sam Alworth is the CEO and co-founder at AcuraStem. With over 20 years of experience in life sciences covering research, drug development, and business development, he actively advances drug candidates for ALS and FTD. Alworth has a technical background in applying artificial intelligence and machine learning to life science assay platforms. He led the implementation of informatics pipelines, inco...